Abbott Laboratories (ABT)
123.67
+3.16 (2.62%)
NYSE · Last Trade: Jul 18th, 5:51 PM EDT
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · July 18, 2025
Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.
Via MarketBeat · July 18, 2025
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record Highstocktwits.com
Via Stocktwits · July 18, 2025
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Via Chartmill · July 18, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 18, 2025
Via Benzinga · July 18, 2025
Via Benzinga · July 18, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.
Via StockStory · July 18, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 17, 2025
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT)
fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but maintained its full-year guidance, which may have disappointed investors hoping for a raised outlook.
Via StockStory · July 17, 2025
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · July 17, 2025
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
Via Benzinga · July 17, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · July 17, 2025
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales.
Via Benzinga · July 17, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said.
Via Stocktwits · July 17, 2025
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via Investor's Business Daily · July 17, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.
Via StockStory · July 17, 2025
Via Benzinga · July 17, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via Chartmill · July 17, 2025